🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Malignant Mesothelioma

An International Study on Pediatric Patients With Rare Tumors. NCT07072143n/a1 site📍 Padova Azienda Ospedaliera di Padova Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining NCT00242723n/a1 site📍 Bethesda National Cancer Institute (NCI) Partial Pleurectomy (Surgery) for Unresectable Pleural Mesothelioma NCT07126509NA1 site📍 Chicago University of Chicago · Tests: Partial Pleurectomy Efficacy and Safety of Ivonescimab Plus Pemetrexed and Platinum-Based Chemotherapy in Advanced Malignant Pleural Mesothelioma NCT07885319Phase 1, Phase 23 sites📍 Shanghai📍 Shanghai📍 Chengdu Ruijin Hospital · Tests: Ivonescimab Combined With Chemotherapy NEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a Feasibility Study NCT07121374Phase 1, Phase 21 site📍 Edegem University Hospital, Antwerp · Tests: Neoadjuvant chemo-immunotherapy, Extended pleurectomy/decortication in case of reaching operability CT-95 in Advanced Cancers Associated With Mesothelin Expression NCT06756035Phase 19 sites📍 Denver📍 Chicago📍 Grand Rapids Context Therapeutics Inc. · Tests: CT-95 Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed NCT01617382n/a1 site📍 Leuven Universitaire Ziekenhuizen KU Leuven A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors NCT07277413Phase 123 sites📍 Goodyear📍 Phoenix📍 Duarte IDEAYA Biosciences · Tests: IDE892, IDE397 Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma NCT05001880Phase 241 sites📍 Phoenix📍 Chicago📍 Chicago National Cancer Institute (NCI) · Tests: Atezolizumab, Bevacizumab, Biospecimen Collection, Carboplatin, Computed Tomography Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma NCT05765084Phase 1, Phase 23 sites📍 Edegem📍 Ghent📍 Sint-Niklaas University Hospital, Antwerp · Tests: Dendritic cell vaccination, Atezolizumab, Platinum/pemetrexed based chemotherapy A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer or Malignant Peritoneal Mesothelioma NCT06623396Phase 17 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: M28z1XXPD1DNR CAR Olaparib in Patients With HRD Malignant Mesothelioma NCT04515836Phase 21 site📍 Chicago University of Chicago · Tests: Olaparib 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection NCT06503146Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: [18F]FAPI-74, [18F]FDG SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma NCT05568680Phase 15 sites📍 Tampa📍 Westwood📍 Philadelphia Verismo Therapeutics · Tests: SynKIR-110, Autologous T cells Transduced with Mesothelin KIR-CAR New Preclinical and Clinical Approaches to Mesothelioma NCT06536179n/a2 sites📍 Naples📍 Milan Marco Emilio Bianchi Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors NCT06239194Phase 1, Phase 26 sites📍 Denver📍 Miami📍 Boston ModeX Therapeutics, An OPKO Health Company · Tests: MDX2001 Long Term Follow-Up of Patients With Mesothelioma and Individuals With Germline Mutations in BAP1 NCT03830229n/a1 site📍 Bethesda National Cancer Institute (NCI) Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors NCT07443020Phase 11 site📍 Pittsburgh Allegheny Singer Research Institute (also known as Alleghen… · Tests: locally manufactured adoptive cellular therapy (ACT) product, Interleukin-2 (IL-2) Genetic Susceptibility in MAlignant Pleural Mesothelioma: Clinical Implication of GermliNE variaTionS NCT06886672n/a2 sites📍 Pavia📍 Pavia Fondazione IRCCS Policlinico San Matteo di Pavia Atezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso) NCT04996017Phase 319 sites📍 Meldola📍 Alessandria📍 Bari Gruppo Oncologico Italiano di Ricerca Clinica · Tests: Atezolizumab 1200 mg in 20 ML Injection, Placebo Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome NCT04792463n/a1 site📍 Columbus Mohamed Abdel-Rahman TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO NCT05628376n/a1 site📍 London University College, London A Study of MT027 in Patients with Pleural Malignant Tumors NCT06726564Phase 11 site📍 Beijing Suzhou Maximum Bio-tech Co., Ltd. · Tests: MT027 cells suspension Integrated Cancer Repository for Cancer Research NCT02012699n/a42 sites📍 Greenwood Village📍 Manchester📍 Daytona Beach University of Nebraska A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas NCT04104776Phase 1, Phase 280 sites📍 Tampa📍 Atlanta📍 Chicago Novartis Pharmaceuticals · Tests: Tulmimetostat, Enzalutamide TLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid Tumors NCT07713732Phase 13 sites📍 Camperdown📍 Malvern📍 Nedlands Treeline Biosciences, Inc. · Tests: TLN-499, Venetoclax Identification of Prognostic and Predictive Biomarkers of Toxicity in Patients With Malignant Pleural Mesothelioma and Treated With High Doses of Radiotherapy (MESORTIBO) NCT06637345n/a1 site📍 Aviano Centro di Riferimento Oncologico - Aviano A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma NCT06057935Phase 213 sites📍 Chicago📍 Ann Arbor📍 St Louis Memorial Sloan Kettering Cancer Center · Tests: Pemetrexed, Cisplatin, Carboplatin SW-682 in Advanced Solid Tumors NCT06251310Phase 18 sites📍 Scottsdale📍 Los Angeles📍 Sacramento SpringWorks Therapeutics, Inc., a healthcare company of Mer… · Tests: SW-682, Combination Therapy A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors NCT06452160Phase 11 site📍 Houston BridGene Biosciences Inc. · Tests: BGC515
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy